HLA-DMA and HLA-DMB genotyping in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 26, Issue 9, 1999, Pages 1930-1933

  Yen, Jeng Hsien ^a   Chen, Chung Jen ^a   Tsai, Wen Chan ^a   Tsai, Jih Jin ^a   Ou, Tsan Teng ^a   Liu, Hong Wen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

HLA DMA; HLA DMB; MHC; Systemic lupus erythematosus

Indexed keywords

HLA DM ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 0033405161     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hahn BH. Pathogenesis of systemic lupus erythematosus. In: Kelley WN, Ruddy S, Harris ED Jr, Sledge CB, editors. Textbook of Rheumatology. 5th ed. Philadelphia: W.B. Saunders; 1997:1015-27.
2. Schur PH. Genetics of systemic lupus erythematosus. Lupus 1995;4:425-37.
3. Tsao BP, Wallace DJ. Genetics of systemic lupus erythematosus. Curr Opin Rheumatol 1997;9:377-9.
4. Tebib JG, Alcocer-Varela J, Alarcón-Segovia D, Schur PH. Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990;1961-7.
5. Dunckley H, Gatenby PA, Hawkins B, Naito S, Serjeantson SW. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987;14:209-18.
6. Hoffman RW, Sharp GC, Irvin WS, Anderson SK, Hewett JE, Pandley JP. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum 1991;34:453-8.
7. Duits AJ, Bootsma H, Derksen RHWM, et al. Skewed distribution of IgG Fc receptor lia (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;39:1832-6.
8. Salmon JE, Millard S, Schachter LA, et al. FcrRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
9. Wu J, Bansal V, Redecha P, Salmon J, Edberg J, Kimberly R. A novel polymorphism of FcrRIIIA, which alters function, associates with the SLE phenotype [abstract]. J Invest Med 1997;45:200A.
10. Davies EJ, Snowden N, Hillarby MC, Carthy D, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995;38:110-4.
11. Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for a linkage of a candidate chromosome 1 region to human systemic lupus erythemalosus. J Clin Invest 1997;99:725-31.
12. Kelly AP, Monaco JJ, Cho S, Trowsdale J. A new human HLA class II-related locus, DM. Nature 1991;353:571-3.
13. Sanderson F, Kleijmeer MJ, Kelly A, et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 1994;266:1566-9.
14. Bodmer JG, Marsh SGE, Albert ED, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Tissue Antigen 1997;4:297-321.
15. Sanderson F, Powis SH, Kelly AP, Trowsdale J. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 1994;39:56-8.
16. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 1990;343:71-4.
17. Fling SP, Arp B, Pilous D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994;368:554-8.
18. Morris P, Shaman J, Attaya M, et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 1994;368:551-4.
19. Yen JH, Chen CJ, Tsai WC, Tsai JJ, Chang JG, Liu HW. HLA-DMA and DMB genotyping in patients with rheumatoid arthritis. J Rheumatol 1997;24:442-4
20. Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 1995;22:1450-4.
21. Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW. HLA-DPB1 polymorphism in patients with rheumatoid arthritis in Taiwan. J Rheumatol 1995;22:2034-7.
22. Chen CJ, Chiang W, Yen JH, Tsai WJ, Tsai JJ, Liu HW. HLA-DQA1 genotyping in patients with systemic lupus erythematosus. In: Proceedings first FIMSA Congress. December 1-5, 1996; Adelaide, Australia. Federation of Immunological Societies of Asia-Oceania; 1996:140.
23. Sloan VS, Cameron P, Porter G, et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995;375:802-6.
24. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996;274:618-20.
25. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996;184:2153-65.
26. Vogt AB, Moldenhauer G, Hammerling GJ, Kropshofer H. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion. Immunol Lett 1997;57:209-11.
27. Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal PH. Immunity 1997;6:293-302.
28. Vogt AB, Kropshofer H, Hammerling GJ. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules. Hum Immunol 1997;54:170-9.
29. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996;15:6144-54.
30. Vogt AB, Kropshofer H, Moldenhauer G, Hammerling GJ. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc Natl Acad Sci USA 1996;9724-9.
31. Sherman MA, Weber DA, Jensen PE. DM enhances peptide binding to a class II MHC by release of invariant chain-derived peptide. Immunity 1995;3:197-205.
32. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αß dimers and facilitates peptide loading. Cell 1995;82:155-65.
33. Kropshofer H, Hammerling GJ, Vogt AB. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today 1997;18:77-82.
34. van Ham SM, Gruneberg U, Malcherek G, Broker I, Melms A, Trowsdale J. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J Exp Med 1996;184:2019-24.
35. Pinet V, Combe B, Avinens O, et al. Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum 1997;40:854-8.
36. Blum JS, Ma Chenglie, Kovats S. Antigen-presenting cells and the selection of immunodominant epitopes. Crit Rev Immunol 1997;17:411-7.
37. Lightstone L, Hargreaves R, Bobek G, et al. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc Natl Acad Sci USA 1997;94:5772-7.